Novavax coronavirus vaccine completely prevents severe illness, but was less effective at preventing infections by variants
A final analysis of the Novavax vaccine candidate in two trials in the United Kingdom and South Africa found it was strongly effective in preventing illness, although less so against the variant first detected in South Africa. The vaccine completely protected against all cases of severe disease.
View original article
Contributor: Carolyn Y. Johnson
